Effect of endothelin a receptor antagonist on hepatic hemodynamics in cirrhotic rats. implications for endothelin-1 in portal hypertension

Tokai Journal of Experimental and Clinical Medicine

Volumn 36, Issue 2, 2011, Pages 37-43

  Takashimizu, Shinji ^a   Kojima, Seiichiro ^a   Nishizaki, Yasuhiro ^a   Kagawa, Tatehiro ^a   Shiraishi, Koichi ^a   Mine, Tetsuya ^a   Watanabe, Norihito ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelin a receptor; Endothelin 1; Hepatic microcirculation; Hepatic stellate cells; Portal hypertension

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HEMODYNAMICS; HEPATIC HEMODYNAMICS; IMMUNOPEROXIDASE STAINING; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER SINUSOID; MALE; MICROCIRCULATION; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RAT; SCANNING ELECTRON MICROSCOPY; SINUSOIDAL ENDOTHELIAL FENESTRA; STELLATE CELL;

ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HYPERTENSION, PORTAL; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICROCIRCULATION; MICROSCOPY, ELECTRON, SCANNING; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A;

EID: 79960411219     PISSN: 03850005     EISSN: 21852243     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Laleman W, Landeghem L, Wilmer A, Fevery J, Nevens F. Portal hypertension: from pathophysiology to clinical practice. Liver Int. 2005; 25: 1079-1090.
2. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988; 332: 411-415.
3. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 1989; 86: 2863-2867.
4. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 1992; 327: 1774-1778.
5. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology. 1996; 110: 534-548.
6. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990; 348: 732-735.
7. Arai H, Hori S, Aramori L, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-732.
8. Rockey DC. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology. 1997; 25: 2-5.
9. Ortega Mateo A, de Artinano AA. Highlights on endothelins: a review. Pharmacol Res. 1997; 36: 339-351.
10. Clozel M, Gray GA, Breu V, Löffler BM, Osterwalder R. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun. 1992; 186: 867-873.
11. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest. 1993; 91: 1367-1373.
12. Watanabe N, Takashimizu S, Nishizaki Y, Kojima S, Kagawa T, Matsuzaki S. An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation. J Gastroenterol. 2007 Sep; 42: 775-782.
13. Takashimizu S, Watanabe N, Nishizaki Y, Kawazoe K, Matsuzaki S. Mechanisms of hepatic microcirculatory disturbances induced by acute ethanol administration in rats, with special reference to alterations of sinusoidal endothelial fenestrae. Alcohol Clin Exp Res. 1999; 23(4 Suppl): 39S-46S.
14. Arvidsson D, Svensson H, Haglund U. Laser-Doppler flowmetry for estimating liver blood flow. Am J Physiol. 1988; 254(4 Pt 1): G471-G476.
15. Gandhi CR, Sproat LA, Subbotin VM. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci. 1996; 58: 55-62.
16. Hamaoki M, Kato H, Sugi M, Fujimoto M, Kurihara H, Yosizumi M, et al. Monoclonal antibodies to endothelin: Application for sandwich immunoassay. Hybridoma. 1990; 9: 63-69.
17. Hiraki H, Hoshi N, Hasegawa H, Tanigawa T, Emura I, Seito T, et al. Regular immunohistochemical localization of endothelin-1 and endothelin-B receptor in normal, hyperplastic and neoplas-tic human adrenocortical cells. Pathol Int. 1997; 47: 117-125.
18. Rockey DC, Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 1996; 24: 233-240.
19. Zhang B, Calmus Y, Wen L, Sogni P, Lotersztajn S, Houssin D, et al. Endothelin-1 induces liver vasoconstriction through both ETA and ETB receptors. J Hepatol 1997; 26: 1104-1110.
20. Elliot AJ, Vo LT, Grossman VL, Bhathal P, Grossman HJ. Endothelin-induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats. J Gastroenterol Hepatol 1997; 12: 314-318.
21. Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA. 1993; 90(20): 9266-70.
22. Stephenson K, Harvey SA, Mustafa SB, Eakes AT, Olson MS. Endothelin association with the cultured rat Kupffer cell: characterization and regulation. Hepatology. 1995; 22: 896-905.
23. Yokomori H, Oda M, Ogi M, Kamegaya Y, Tsukada N, Nakamura M, et al. Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver. Liver. 2001; 21: 114-122.
24. Zhang JX, Pegoli W, Clemens M. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol. 1994; 266(4 Pt 1): G624-G632.
25. Feng HQ, Weymouth ND, Rockey DC. Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease. Am J Physiol Gastrointest Liver Physiol. 2009; 297: G27-G33.
26. Chan CC, Wang SS, Lee FY, Chang FY, Lin HC, Chu CJ, et al. Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats. Hepatology. 2001; 33: 816-820.
27. Wisse E, De Zanger RB, Charles K, Van Der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 1985; 5: 683-692.
28. Braet F, Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp Hepatol. 2002; 1: 1.
29. Schaffner N, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology 1963; 44: 239-242.